Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Go to Main Navigation
Nov 6, 2012

The US presidential election will soon come to a close today and many Americans will have casted their vote for the candidate who they believe will...

Nov 1, 2012

Our latest infographic touches on a subject we care deeply about: the cost of drug discovery and the need for cost-effective research and...

Oct 30, 2012

It seems as if hardly a week goes by now without reading about a new example of crowdsouricing or citizen scientists working on some of the most...

Oct 23, 2012

In our efforts to bring exposure to rare disease research through our Rare Disease Challenge, we’ve learned that only about 5% of the rare diseases...

Oct 22, 2012

Curing or even finding treatments for rare diseases is hard. Not necessarily because these diseases are any more complex than more common ones. It...

Oct 18, 2012

Scientist’s CEO, Kevin Lustig, spoke in a recent episode of the Burrill Report about the Open Science movement and how the democratization of drug...

Oct 16, 2012

Scientist is pleased to announce the Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries). We are working...

Oct 15, 2012

In James Surowiecki’s book “The Wisdom of Crowds”, he lays out the criteria for successful decision making by large groups1: Diversity of opinion...

Oct 9, 2012

The Make Your Mark competition, part of Scientist’s Open Science Challenge series, is now officially live in San Diego, New York, and Boston...

Oct 5, 2012

For decades the model for how a clinical diagnostic assay (otherwise known as a clinical diagnostic, or a diagnostic test) was developed remained...